GlassScriptPhysician profile
Jeanne A King
NPI 1033239629
$43,087.51
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $22K · 2021: $20K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $42,508.26 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $192.73 | 2019 | |
| Eisai INC. | $115.31 | 2019 | |
| Alexion Pharmaceuticals, INC. | $94.01 | 2019 | |
| Greenwich Biosciences, INC. | $92.64 | 2021 | |
| Livanova USA, INC. | $32.73 | 2019 | |
| Genzyme Corporation | $14.46 | 2019 | |
| Lundbeck LLC | $14.35 | 2019 | |
| Ucb, INC. | $11.82 | 2019 | |
| Biogen, INC. | $11.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanne King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.